FDX
58
-2
INTC
62
4
KMI
51
5
CHK
39
4
NVDA
60
4
RCL
66
-3
IBM
71
-3
DE
28
-2
DNB
42
-2
WAT
41
3
SEE
36
3
TRIP
55
-3
EQIX
52
-2
ZION
57
-3
ETR
44
-2
FIS
48
2
DG
18
-8
MAC
64
4
REGN
62
-3
BRK.B
36
-2
FDX
58
-2
INTC
62
4
KMI
51
5
CHK
39
4
NVDA
60
4
RCL
66
-3
IBM
71
-3
DE
28
-2
DNB
42
-2
WAT
41
3
SEE
36
3
TRIP
55
-3
EQIX
52
-2
ZION
57
-3
ETR
44
-2
FIS
48
2
DG
18
-8
MAC
64
4
REGN
62
-3
BRK.B
36
-2
Financhill
Back

Actinium Pharmaceuticals 10K Form

Sell
29

ATNM
Actinium Pharmaceuticals

Last Price:
7.25
Seasonality Move:
0.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATNM News And Ratings

See the #1 stock for the next 7 days that we like better than ATNM

ATNM Financial Statistics

Sales & Book Value

Annual Sales: $81K
Cash Flow: $-7.39M
Price / Cash Flow: 0
Annual Sales: $1.49
Price / Book: 4.94

Profitability

EPS (TTM): -1.71000
Net Income (TTM): $-46.45M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Actinium Pharmaceuticals Earnings Forecast

Key Actinium Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for ATNM have been equal to 16,458.02% of Gross Profit Margin.
  • The Research & Development expenses have been 47,740.74% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

Actinium Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATNM
CUSIP: 00507W
Website: actiniumpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATNM Technical Analysis vs Fundamental Analysis

Sell
29
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy or a Sell?